Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - directed
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Serum Protein Biomarkers that Predict the Response to Liver
Directed
Therapy in Methymalonic Acidemia (MMA) and Propionic Acidemia (PA)
Isolated Methylmalonic Acidemia (MMA) comprises a relatively common and heterogeneous group of inborn errors of metabolism. The most common cause of isolated MMA is genetic deficiency of the enzyme methylmalonyl-coA mutase (MUT), which, unfortunately for the affected patients, is also the most clinically severe. NHGRI scientist have discovered biomarkers...
Published: 10/28/2024
|
Inventor(s):
Eirini (Irini) Manoli
,
Charles Venditti
Keywords(s):
Acidemia
,
Biomarkers
,
Directed
,
liver
,
Methymalonic
,
MMA
,
PREDICT
,
Protein
,
RESPONSE
,
SERUM
,
That
,
THERAPY
,
VPXXXX
,
WBXXXX
,
WIXXXX
,
XCXXXX
,
XEXXXX
Category(s):
Application > Diagnostics
,
TherapeuticArea > Ophthalmology
,
Application > Research Materials
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Oncology
,
TherapeuticArea > Dental
,
TherapeuticArea > Endocrinology
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
Non-invasive Isotopic Biomarkers that Predict the Response to Liver
Directed
Therapy in Methymalonic Acidemia (MMA) and Propionic Acidemia (PA)
Isolated Methylmalonic Acidemia (MMA) comprises a relatively common and heterogeneous group of inborn errors of metabolism. The most common cause of isolated MMA is genetic deficiency of the enzyme methylmalonyl-coA mutase (MUT), which, unfortunately for the affected patients, is also the most clinically severe. NHGRI scientist have invented a series...
Published: 10/28/2024
|
Inventor(s):
Eirini (Irini) Manoli
,
Charles Venditti
Keywords(s):
Acidemia
,
Biomarkers
,
Directed
,
ISOTOPIC
,
liver
,
Methymalonic
,
MMA
,
NON-INVASIVE
,
PREDICT
,
RESPONSE
,
That
,
THERAPY
,
VPXXXX
,
WFXXXX
,
WIXXXX
,
XCXXXX
Category(s):
Application > Occupational Safety and Health
,
Application > Research Materials
,
Application > Diagnostics
,
TherapeuticArea > Dental
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Endocrinology
,
Application > Consumer Products
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Oncology
Human DNA Polymerase Gamma for Testing the Effect of Drugs on Mitochondrial Function
One of the primary means for treating HIV infection is the use of antiviral nucleotide or nucleoside analogs. These analogs work by inhibiting the activity of reverse transcriptase, the enzyme responsible for preparing the HIV genome for integration into the DNA of the host cell. Although these analogs do not have an effect on the polymerases responsible...
Published: 10/28/2024
|
Inventor(s):
Rajesh Kasiviswanathan
,
Susan Lim
,
William Copeland
Keywords(s):
CLONE
,
DDXXXX
,
DEFICIENT
,
Directed
,
DNA
,
DXXXXX
,
Enzyme
,
EXONUCLEASE
,
Expression
,
Gamma
,
Human
,
Improved
,
Includes
,
Listed LPM Campbell as of 4/15/2015
,
Method
,
Modifications
,
polymerase
,
Polymerase.
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
purification
,
recombinant
,
RXXXXX
,
SITE
,
TYPE
,
VLXXXX
,
Which
,
Wild
,
WIXXXX
,
XEXXXX
,
YBXXXX
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
Therapeutic Methods Based on In Vivo Modulation of the Production of Interferon gamma
The technology offered for licensing is in the field of Therapeutics. More specifically, the technology relates to biological ligands and their use as modulators of the production of Interferon gamma as a means to treat a broad spectrum of diseases. The invention describes and claims antibodies and other ligands that can stimulate Natural Killer (NK)...
Published: 10/28/2024
|
Inventor(s):
Sumati (Sumi) Rajagopalan
,
Eric Long
Keywords(s):
Against
,
antibodies
,
DB3XXX
,
DB4XXX
,
DBXXXX
,
DC1XXX
,
DCXXXX
,
Directed
,
DXXXXX
,
Gamma
,
INTERFERON
,
KIR2DL4
,
LIGANDS
,
Patent Category - Biotechnology
,
production
,
RECEPTOR
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines